BethEllenCohenMDMAS

Internal Medicine • San Francisco, CA

Staff Physician, San Francisco VA Healthcare System/Associate Professor in Residence, Internal Medicine, UCSF School of Medicine

Join to view full profile

Dr. Cohen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cohen's full profile

Already have an account?

Office
4150 Clement St
Sfvamc Medical Practice 1
San Francisco, CA 94121
Phone+1 415-750-2129

Fax+1 415-750-6614

Education & Training

University of California (San Francisco)Residency, Internal Medicine, 2003 - 2006
University of California San Francisco School of MedicineClass of 2003

Certifications & Licensure

CA State Medical License 2005 - 2026
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Cannabis legalization and changes in cannabis and tobacco/nicotine use and co-use in a national cohort of U.S. adults during 2017-2021.
Vira Pravosud, Stanton Glantz, Salomeh Keyhani, Pamela M Ling, Lauren K Lempert
The International Journal on Drug Policy. 2024-12-01
Receipt of Smoking Cessation Medications and Smoking Abstinence Among Veterans Prescribed Opioid Analgesics With and Without Cannabis Use.
Nhung Nguyen, Samuel Leonard, Beth E Cohen, Ellen D Herbst, Katherine J Hoggatt
Journal of General Internal Medicine. 2024-11-11
Changes in Sources of Information about the Risks and Benefits of Cannabis in a National Cohort of US Adults from 2017 - 2021.
Francis Julian L Graham, Salomeh Keyhani, Pamela Ling, Vira Pravosud, Nhung Nguyen
Journal of Studies on Alcohol and Drugs. 2024-10-23

Press Mentions

More Adults Think Marijuana Safer Than Tobacco Despite Similar Health Dangers, Study FindsAugust 12th, 2023
SLU Research: PTSD Is a Modifiable Risk Factor for Type 2 Diabetes, Related Adverse OutcomesAugust 22nd, 2024